Sudhanshu P. Raikwar, PhD, BVSc & AH, MVSc

Assistant Research Professor

University of Missouri – Columbia (MU)

Alzheimer’s Disease is a progressive neurodegenerative disorder that leads to dementia and affects nearly 26 million people worldwide. Currently, only disease modifying therapies that might reduce or possibly halt the progression of the disease are available while the effective cure remains elusive. Hence, there is an urgent need to develop the next generation patient-specific therapies to treat Alzheimer’s Disease. Therefore the long term goal of my research is to develop a precision guided gene and stem cell based therapy for the treatment of Alzheimer’s disease. Towards achieving the long term goal, I will develop translational research strategies for the treatment of Alzheimer’s disease pathophysiology especially by simultaneously co-targeting neuro-inflammation and neuro-degeneration using CRISPR-Cas9 based gene editing in Alzheimer’s Disease mouse models.